Broadwood Partners opposes STAAR Surgical sale to Alcon amid proxy concerns
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
December 16, 2025 7:00 AM ESTISS Says It Would Not Be Unreasonable for a Shareholder to Remain Opposed to the Deal
Broadwood Encourages Shareholders to Follow the Recommendations of Proxy Advisory Firms Glass Lewis and Egan-Jones, Both of Whom Recommend Shareholders Vote AGAINST the Proposed Transaction
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on a report published by Institutional Shareholder Services Inc. (ISS), an independent proxy advisory firm, which reiterates that firms significant concerns regarding the proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
